drugset / Trial / NCT03732508
SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the progression-free survival (PFS) of Chemotherapy combined with SHR-1316 in patients with advanced esophageal squamous cell cancer.
Timeline
- Start
- 2018-11
- Primary completion
- 2019-11
- Completion
- 2020-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Adebrelimab | Monoclonal antibody | — | Intravenous |
| Subject | Irinotecan liposome | Unknown | — | Intravenous |
| Subject | fluorouracil | Small molecule | — | Intravenous |